Literature DB >> 20441051

Cell survival or apoptosis: rooperol's role as anticancer agent.

Gerhardt J Boukes1, Brodie B Daniels, Carl F Albrecht, Maryna van de Venter.   

Abstract

Nontoxic hypoxoside, isolated from Hypoxis, is converted to cytotoxic rooperol in the presence of beta-glucosidase. In this study, we investigated rooperol's mechanism of action. IC50 values of hypoxoside and rooperol were determined against the HeLa, HT-29, and MCF-7 cancer cell lines, and peripheral blood mononuclear cells. DNA cell cycle arrest occurred in late G1 and/or early S phases, associated with increased p21(Waf1/Cip1) levels. Apoptosis was shown by caspase-3 and/or caspase-7 activation, phosphatidylserine translocation, DNA fragmentation, cell blebbing, and apoptotic body formation. Increased phospho-Akt, phospho-Bcl-2, and p21(Waf1/Cip1) proteins, and cell size correspond to cell survival strategies (associated with endoreduplication).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20441051     DOI: 10.3727/096504010x12644422320627

Source DB:  PubMed          Journal:  Oncol Res        ISSN: 0965-0407            Impact factor:   5.574


  2 in total

1.  Selective ROS-dependent p53-associated anticancer effects of the hypoxoside derivative rooperol on human teratocarcinomal cancer stem-like cells.

Authors:  Sarah Ali Azouaou; Fathi Emhemmed; Noureddine Idris-Khodja; Annelise Lobstein; Valérie Schini-Kerth; Christian D Muller; Guy Fuhrmann
Journal:  Invest New Drugs       Date:  2014-11-19       Impact factor: 3.850

2.  Scalable Synthesis and Cancer Cell Cytotoxicity of Rooperol and Analogues.

Authors:  Zachary T Schwartz; Peter D Theisen; Olaf T Bjornstal; Mary Rodebaugh; Mauricio A Jemal; Dallas Lee; Spencer D Shelton; Zhenze Zhao; Liqin Du; Sean M Kerwin
Journal:  Molecules       Date:  2022-03-09       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.